Skip to main content
Have a personal or library account? Click to login
Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target / Fenotipska heterogenost u staničnoj liniji NCI-H125 utječe na biološku aktivnost na receptore za epidermalni faktor rasta Cover

Phenotypic heterogeneity in the NCI-H125 cell line affects biological activity using the epidermal growth factor receptor as target / Fenotipska heterogenost u staničnoj liniji NCI-H125 utječe na biološku aktivnost na receptore za epidermalni faktor rasta

Acta Pharmaceutica
Volume 62 (2012): Issue 4 (December 2012)
By: ,  ,  ,  ,   and    
Open Access
|Jan 2013
References

References

  1. 1. R. S. Herbst, Review of epidermal growth factor receptor biology,(2004) 21-26; DOI: 10.1016/j.ijrobp.2003.11.041.
    Open DOISearch in Google Scholar
  2. 2. H. Zhang, A. Berezov, Q. Wang, G. Zhang, J. Drebin, R. Murali and M. I. Greene, ErbB receptors: from oncogenes to targeted cancer therapies,(2007) 2051-2058; DOI: 10.1172/JCI32278.
    Open DOISearch in Google Scholar
  3. 3. A. Kendall, R. Lord and N. Maisey, Anti-epidermal growth factor receptor antibodies in the treatment of metastatic colorectal cancer,(2010) 142-151; DOI: 10. 2174/157489210790936270.
    Open DOISearch in Google Scholar
  4. 4. M. S. Ramakrishnan, A. Eswaraiah, T. Crombet, P. Piedra, G. Saurez, H. Iyer and A. S. Arvind, Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin,(2009) 41-48; DOI: 10.4161/mabs.1.1.7509.
    Open DOISearch in Google Scholar
  5. 5. R. C. Chatelier, R. G. Ashcroft, C. J. Lloyd, E. C. Nice, R. H. Whitehead, W. H. Sawyer and A.W. Burgess, Binding of fluoresceinated epidermal growth factor to A431 cell sub-populations studied using a model-independent analysis of flow cytometric fluorescence data,(1986) 1181-1186.
    Open DOISearch in Google Scholar
  6. 6. N. B. S. Abid, Z. Rouis, F. Nefzi, N. Souelah and M. Aouni, Evaluation of dimethylthiazol diphenyl tetrazolium bromide and propidium iodide inclusion assays for the evaluation of cell viability by flow cytometry,(2012) 10-14; DOI: 10.7324/JAPS.2012.2525.
    Open DOISearch in Google Scholar
  7. 7. A. L. Givan,, in(Eds. R. Diamond and S. DeMaggio), 1st ed., Springer, Berlin 2000, pp. 142-164.
    Search in Google Scholar
  8. 8. W. K. Boland and G. Bebb, Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity,(2009) 1-8; DOI: 10.1517/14712590903110709.
    Open DOISearch in Google Scholar
  9. 9. J. M. Reichert, Antibody-based therapeutics to watch in 2011,(2011) 76-99; DOI: 10.4161/mabs.3.1.13895.
    Open DOISearch in Google Scholar
  10. 10. R. I. Freshney,, in(Eds. G. Vunjak-Novakovic and R. I. Freshney), John Wiley, New York 2006, pp. 11-14.
    Open DOISearch in Google Scholar
  11. 11. G. Rothe,, in(Eds. U. Sack, A. Tarnok and G. Rothe), Karger, Basel 2009, pp. 53-88; DOI: 10.1159/000209156.
    Open DOISearch in Google Scholar
  12. 12. G. N. Gill and C. S. Lazar, Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells,(1981) 305-307.
    Open DOISearch in Google Scholar
  13. 13. L. Nikfarjam and P. Farzaneh, Prevention and detection of mycoplasma contamination in cell culture,(2012) 203-212.
    Search in Google Scholar
  14. 14. T. Mammone, D. Gan and R. Foyouzi-Youssefi, Apoptotic cell death increases with senescence in normal human dermal fibroblast cultures,(2006) 903-909; DOI: 10.1016/j.cellbi.2006.06.010.
    Open DOISearch in Google Scholar
  15. 15. S. Gupta, S. R. Indelicato, V. Jethwa, T. Kawabata, M. Kelley, A. R. Mire-Sluis, S. M. Richards, B. Rup, E. Shores, S. J. Swanson and E. Wakshull, Recommendations for the design optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics,(2007) 1-18; DOI: 10.1016/j.jim.2004.06.002.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/v10007-012-0038-6 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English, Croatian, Slovenian
Page range: 581 - 591
Published on: Jan 15, 2013
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
cell viability,
morphological changes,
biological activity,
epidermal growth factor receptor,
nimotuzumab,
vijabilnost stanice,
morfološke promjene,
biološko djelovanje,
receptori za epidermalni faktor rasta,
nimotuzumab
Related subjects:
Pharmacy,
Pharmacy, other

© 2013 Rancés Blanco, Mercedes Cedeño, Narjara González, Reynier Rodríguez, Javier Sánchez, Enrique Rengifo, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.

Volume 62 (2012): Issue 4 (December 2012)
Previous article
Next article